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Abstract
Background: There is no standardized method for the assessment of physical activity (PA). Therefore it is important
to investigate the validity and comparability of different measures. The International Physical Activity Questionnaire
(IPAQ) has been developed as an instrument for cross-national assessment of PA and has been validated in 12 countries.
These instruments have acceptable measurement properties for monitoring population levels of PA among 18–65 year-
old adults in diverse settings. However, there are some concerns that IPAQ may over-report PA.
The purpose of this study is to evaluate the reliability and validity of IPAQ, short version, last 7-days in the Nord-
Trøndelag Health Study (HUNT) population of men.
Methods: The questionnaire was administered twice to a random sample of 108 men aged 20–39 and validity by
comparing results with VO2max and ActiReg, an instrument that measures PA and energy expenditure (EE). ActiReg
discriminates between the body positions: stand, sit, bend forward and lie and also registers if there is motion or not in
each of them or both.
Results: Our results for reliability of the IPAQ short version were good for vigorous and fair for moderate activities.
Intraclass correlations ranged from a low of 0.30 for moderate activity hours, to a high of 0.80 for sitting hours.
Concerning validity, our results suggest that total IPAQ vigorous PA was a moderately good measure of vigorous activity,
having moderately strong, significant correlations with VO2max, r = 0.41 (p ≤ 0.01), but correlated not with metabolic
equivalent (METs) values of 6 or more measured with ActiReg. Only total IPAQ walking was fair correlated with METs
1–3 and METs 3–6, respectively r = -0.27 and 0.26 (p ≤ 0.05). The index for IPAQ sitting hours per week was moderate
correlated with METs values of 1–3 and negatively correlated with METs values of 3–6. Classification of PA in three levels
(low, moderate and high) correlated also most strongly with VO2max (0.31 p ≤ 0.01) and METs 3–6 and METs 1–3 from
ActiReg (r = 0.32 and -0.31, p ≤ 0.01). Classification of BMI in three levels (normal, overweight and obese) correlated
most strongly negative with VO2max (-0.42 p ≤ 0.01) and MJ from ActiReg (r = 0.31 p ≤ 0.01).
Conclusion: Our results indicate that IPAQ short version for men has acceptable reliability and criterion validity for
vigorous activity and sitting. Walking has moderate reliability. Only the IPAQ for walking had a fair correlation with METs
6+. The questions about moderate activity had fair reproducibility and correlated poorly with most comparison
measures.
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Questionnaires are typically used in epidemiologic stud-
ies to assess physical activity (PA) levels, but the absence
of widely accepted standardized methods and the use of
different PA measures hinders national and international
comparisons. However, the International Physical Activity
Questionnaire (IPAQ) has been developed as an instru-
ment for cross-national assessment of PA and has now
been validated in 12 countries [1]. These instruments have
acceptable measurement properties for monitoring popu-
lation levels of PA among 18–65 years old adults in
diverse settings. Long and short versions of the IPAQ are
available which can be administered by telephone inter-
view or self-administration. Two reference periods can be
investigated, either the "last 7 days or "usual week". Over-
reporting of PA, especially of time and intensity [2], may
be a problem in self-reported assessments, and there are
some concerns that IPAQ may share this tendency.
Validity and reliability of the IPAQ has been addressed in
several studies. One study has addressed possible over-
reporting in IPAQ, using the short last 7 day, telephone
interview (IPAQ-S7T) [3]. In the European Physical Activ-
ity Surveillance System (EUPASS) researchers have com-
pared several PA measures, including IPAQ, in a time
series in eight countries of the European Union, highlight-
ing methodological implications of the IPAQ (computer-
aided telephone interviewing) [4]. In another study, Rüt-
ten et al. [5] concluded that more research is needed to
further investigate and improve the quality of the IPAQ
(telephone interviewing). A Chinese version of IPAQ
(long and short version) appeared to have acceptable reli-
ability and validity, compared to other PA instruments
used in various large epidemiological studies, although
the short version underestimated the energy expenditure
(EE) of total and moderate PA [6]. Hallal & Victora [7]
reported that the short version may systematically under-
estimate PA levels in Brazilian adults. A recent study sug-
gested IPAQ is a reliable and valid measurement of total
PA in a Chinese population, however the sub-compo-
nents of total activity were less valid and reliable, (short,
last 7 days) [8].
To our knowledge, when this study started, no one had yet
criterion-validated IPAQ against physical fitness measures
even though IPAQ was designed to measure particularly
activities related to cardiorespiratory fitness [1]. However,
Fogelholm [9] has later published a study comparing the
IPAQ against VO2max, measured by submaximal ergom-
eter cycle testing (self-administered IPAQ short format,
last 7 days, S7S). A recent study by Ekelund et al. [10] also
examined the short IPAQ, last 7 days version in Swedish
adults, claiming their study to be the first to evaluate the
absolute time spent in moderate and vigorous PA from
the IPAQ questionnaire.
The purpose of this study is to evaluate the reliability and
validity of the IPAQ short version questionnaire in a Nor-
wegian sample of the Nord-Trøndelag Health Study
(HUNT) population of men. It is unique in that we assess
validity by directly comparing questionnaire results with
direct measurements of PA and energy expenditure (EE)
assessed with a position and motion sensor, ActiReg, as
well as indirectly by comparing with VO2max.
Methods
Subjects
For this study 108 men, aged 20–39 were randomly
selected from the population of Levanger and Verdal, two
of the communities included in the Nord-Trøndelag
Health Study (HUNT). They were selected with the goal to
be representative of the current population of young adult
men in the area. 250 were randomly selected by a statisti-
cal service and invited; 108 accepted. With the sample size
of 100, the study had an estimated 88% power to detect a
correlation of 0.3 between the score from the IPAQ ques-
tionnaire and VO2max. The population of Nord-Trøndelag
is stable with sex- and age distributions similar to those of
Norway as a whole, but with somewhat lower levels of
education and income compared to national averages.
An invitation letter was mailed with a pre-addressed, post-
age paid envelope, which was to be completed and
returned; participation was voluntary. Height was meas-
ured without shoes with a wall-mounted tape measure,
and weight with a laboratory scale (Heine Professional,
7800) at the test laboratory of Nord-Trøndelag University
College. Body mass index (BMI) was computed as weight
in kilograms divided by height in meters squared. We also
recoded BMI in a categorical score, classified into three
levels ("normal" (< 25 kg/m2), "overweight" (25–29.99)
and "obese" (≥30 kg/m2).
The study was approved by The Norwegian Data Inspec-
torate Board (IRB) and each subject gave his written
informed consent prior to participation in the study. Fur-
ther, the Regional Committee for Ethics in Medical
Research recommended the protocol.
Survey measures of IPAQ short version, self-administered 
last 7 days (IPAQ-S7S)
PA was assessed using the IPAQ-S7S translated into Nor-
wegian by The Norwegian Directorate of Health and Serv-
ices. We used the instructions given in the IPAQ manual
for reliability and validity, which is detailed elsewhere
[1]http://www.ipaq.ki.se.
To sum up the single indicators to an overall indicator of
PA-related EE (Metabolic equivalent, MET min -1) is a
major goal of the IPAQ instruments. We used the recom-
mended, following MET estimates of IPAQ: Vigorous PA =Page 2 of 9
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METs. For calculating the overall METs PA, each category
was multiplied with its special MET estimate value (we
call it IPAQ METs). We also did some recoding: if some-
one said they "never" walked or walked "0" days per week,
then hours per day and minutes per day were coded as
"0".
We also used the recommended categorical score, three
levels of PA (low, moderate and high) as proposed in
IPAQ Scoring Protocol (short form). Low activity repre-
sented individuals who do not meet the criteria for mod-
erate and vigorous intensity categories (< 599 MET-min/
week). Moderate activity represented moderate – or vigor-
ous -intensity activities achieving a minimum of at least
600 Met-min/week. High activity represented achieving a
minimum of a least 3000 Met-min/week.
Before the VO2max test, participants completed the self-
administered IPAQ short version. This version consists of
7 questions addressing PA, over the last 7 days in all con-
text of everyday life. Addressing days, hours and minutes
per week in vigorous PA, moderate activity, walking and
sitting during a weekday. For each intensity group we
recoded a total IPAQ by computing an index of days,
hours and minutes. These questions from IPAQ we also
calculated METs and hours per week in vigorous and
moderate activities, walking and sitting, as described by
Craig et al. [1] and already mentioned.
Reproducibility
Reliability was evaluated by the asking each subject to
complete the questionnaire one week after first taking it,
using a test-retest design.
Validity
In the absence of a true "gold standard" and as PA is a
multidimensional exposure, we evaluated validity by
comparing the PA data from the self-reported IPAQ with
several measures related to PA: VO2max and five measures
of PA assessed with ActiReg – Megajoule (MJ) per day,
hours at metabolic equivalent (METs) > 6, hours at METs
3–6, hours at METs 1–3 average per day and physical
activity level (PAL), defined as total EE divided by basal
metabolic rate (BMR) [11]. As many others studies, we
used VO2max [12,13] which reflects fitness, as an indicator
of PA-related fitness or aerobic training. A correlation
between VO2max and PA assessed using the questionnaire
would suggest that the questionnaire was measuring
aspects of PA, such as aerobic training-related fitness level.
The measures obtained from ActiReg reflect different
aspects of PA, measured more directly.
We have used the first test of IPAQ in comparison against
VO2max and ActiReg, which means that the participants
were not familiar with the questionnaire and they were
not given a "training round".
Testing for Maximal oxygen uptake (VO2max)
For measuring VO2max (ml·kg-1·min-1) Metamax II (Cor-
tex Biophysic GmbH, Leipzig, Germany), a metabolic
analyzer was used (serial no. MII 63 229 901). The instru-
ment was used stationary at the physiological test labora-
tory at Nord-Trøndelag University College. It recorded
and displayed data at 10 s averages which was transferred
to a PC using the programme Cortex Metasoft. The Meta-
max II oxygen analysers has been examined in a study
using the Douglas bag technique as the control method
[14]. The instrument has built-in sensors for O2, CO2, a
barometer and a thermometer which measure the flow of
the breathed air by means of a turbine flow meter attached
to the breathing mask or mouthpiece. The instrument was
calibrated against ambient air and a commercial gas of
known concentrations of O2 (16.00%) and CO2(4.00%)
in the morning before the start of each experiment. The
concentration of O2 and CO2 of room air was read and the
flow transducer was calibrated using a 3 -L high-precision
calibration syringe (Calibration syringe D, SensorMedics,
Yorba Linda, CA) before testing a new subject.
The subjects were instructed not to eat or smoke at least 2
hours before the test. Water could be taken as needed at
any time. No unusual physical activity efforts should have
been performed at least 12 hours before testing, and sub-
jects were to dress appropriately for exercise, especially
with regard to footwear.
Before the VO2max test the participants also signed a state-
ment that they were healthy and fit for the VO2 max test
on treadmill; all 108 participants declared themselves fit.
A maximal treadmill exercise test was performed to test
VO2max in accordance with recommendations [15]. The
speed was increased gradually and the incline was steady
at 5%. Before the test, subjects had warmed up for 15 min
at 5% gradient and individual speed. After the warm up
the subjects prepared to start the test after 2–3 minutes
break. The test started with 2 minutes of exercise intensity
corresponding to approximately 60% of VO2max. This
intensity was estimated during the warm up. After 2 min-
utes the treadmill speed increased gradually during 1
minute to a level that brought the subject close to exhaus-
tion in approximately 3–4 minutes. This workload should
have been kept up for 3–5 minutes. We asked subjects to
continue for 4 minutes. After 2 minutes the respiratory
quotient (RQ) should be at least 1.00. If it was lower, the
speed was increased, if the RQ was greater than 1.20 we
had to reduce the speed. During the last 2 minutes the
workload could not increase, but before that it's possible
to increase the workload up to 10%. During the test, RQPage 3 of 9
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the O2 uptake showed no further increase or increased
only slightly with a further increase in the treadmill speed
and if the RQ ≥ 1.05 the test was considered successful.
Otherwise the run was continued until a levelling-off was
seen or until exhaustion. A subject's VO2max was taken as
the median of the three successive highest O2 registra-
tions.
ActiReg for measurement of PA and EE
In order to measure total EE, intensity of expenditure and
time spent at various intensity level a relatively new
instrument, ActiReg (PreMed AS, Oslo, Norway) was
employed. ActiReg is an electromechanical device, which
records the main body positions (stand, sit, bent forward
and lie) together with motion of the trunk and/or one leg
each second [16]. The position (tilt switches) and motion
sensors are fixed to plastic brackets. During registration
the subjects wear ActiReg in a belt and the sensors are con-
nected to the box with thin cables. The brackets are
attached by medical tape to the subject's chest (on ster-
num) and on the front of the right thigh approximately
midway between the knee and the hip. The tilt switches
are oriented so that they will be in the vertical position
when the subject is standing.
A dedicated computer program (ActiCalc32) calculates EE
and activity pattern from the collected information and
calibration data [16]. The calculation model used by
ActiCalc32 are based on the estimated cost of the actual
body position and activity expressed as physical activity
ratios (PAR) values (i.e. EE/RMR) combined with the
number of position changes within each minute. PAR val-
ues used by the ActiCalc32 program during calculation of
EE are published reference values for people with normal
body weight [17]. The ActiReg system has been validated
both against doubly labeled water and indirect calorime-
try [16]. More details about the method are published
elsewhere [16]. Thus each minute of the registration
period is characterized according to its estimated PAR-
value which can then be categorized into light, moderate
and vigorous activity, such as METs 1–3, METs 3–6 and
METs 6+.
After VO2max testing participants were instructed how to
wear ActiReg. In addition participants received an illustra-
tion with written instructions and a memory list about the
use of ActiReg. They wore ActiReg for 7 consecutive days,
all hours except while sleeping. For 15 people, fewer than
7 days were available, and they were excluded. We base
results only on the days with measurements.
Data analysis
Statistical analyses were performed with SPSS, Inc., Chi-
cago IL, version 15.0. Sample Power 2 was used to esti-
mate the required sample size. To evaluate reliability, we
calculated single measure intraclass correlation coeffi-
cients (ICC). A 95% confidence interval (CI) was used to
describe the variety/difference in the ICCs. To assess valid-
ity, we used Spearman correlation coefficients to measure
the association of the questionnaire responses with
VO2max and ActiReg results. We also used Pearson correla-
tion coefficients for comparison. We used ordinary least
squares regression to assess and to adjust for possible cov-
ariates, but present results only from the Spearman corre-
lation analyses since our results and conclusions were
similar with other methods. Agreement between self-
reported time spent in total IPAQ moderate and total
IPAQ vigorous PA and measured time spent at the same
intensity level by ActiReg was assessed with an Bland-
Alman technique [18]. We plotted the difference between
the criterion-measured (by ActiReg) time spent in METs
3–6 and METs 6+ and self-reported total IPAQ moderate
and total IPAQ vigorous PA against the criterion.
Results
As shown in Table 1, the mean age of study subjects (N =
108) is 32.4 years and the means for weight, height and
BMI are 85.5 kg, 180.2 cm and 26.3, respectively. Sixteen
in the group who were 20–29 years of age and 45 in the
group who were 30–39 years of age were classified as pre-
obese (BMI 25.0–29.9), based on WHO's classification of
BMI; four and nine in each age group, were in Obesity
class 1 (BMI 30.0–34.9).
Maximal oxygen uptakes were generally comparable to
age-specific "normal" values [19], although the age-spe-
cific averages for men in this study were slightly higher.
Ten in the group 20–29 years of age, and eight in the
group 30–39 years of age had a somewhat low oxygen
consumption, whereas four and twelve, respectively, had
a high oxygen consumption in relation to classification of
VO2max [20],
Table 2 presents means and standard deviations of
selected measures of physical activity and fitness for sub-
jects in this study. The mean (standard deviation) VO2max
was 45.99 (6.24) and the mean (standard deviation) daily
EE was about 12.7 MJ (1.82).
Questionnaire Reliability
Table 3 gives ICC for the IPAQ questionnaires (N = 108).
Correlations ranged from a low of 0.30 for moderate
activity hours, to a high of 0.80 for sitting hours.
Validity
Associations with ActiReg and VO2max
As can be seen in Table 4, VO2max which is sometimes
referred to as a criterion measure of fitness, tended to
increase as the hours with vigorous activity increased, upPage 4 of 9
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monotonic, possibly reflecting the small number of sub-
jects in some categories. However, those with 4–6 hours
of vigorous PA had the highest mean of VO2max (49.2).
When VO2max data were categorized into 2 or 3 groups,
there was a clear trend showing a higher activity levels
with increased fitness level. However, the differences were
not significant, due to the nature of the activity scores
which have zero values. This leads to high SD scores. The
trends for other measures are less consistent.
To further assess validity, we examined the correlation of
the self-reported IPAQ responses with VO2max and with
selected measures from ActiReg. Spearman correlation
coefficients are presented in Table 5. For VO2max, the cor-
relation was highest with the total vigorous PA (r = 0.41 p
≤ 0.01), vigorous hour PA per week (0.40 p ≤ 0.01) and
vigorous days (0.36 p ≤ 0.01) and IPAQ Mets (0.30 p ≤
0.01). For EE (MJ), the correlations with the questionnaire
responses were positive for IPAQ METs (r = 0.26, p ≤ 0.05)
and negative for sitting hours per week (r = – 0.25, p ≤
0.05). Sitting hours per week was also significantly nega-
tive with PAL (r = -0.35, p ≤ 0.01) as well as with METs 1–
3 (r = 0.44, p ≤ 0.01) and METs 3–6 (r = -0.42, p ≤ 0.01).
The time spent in activities with METs values 6+ based on
ActiReg most strongly correlated with hours walking per
week as measured with IPAQ (r = 0.23, p ≤ 0.05) and total
walking correlated most strongly with METs 1–3, METs 3–
6 and METs 6+ (respectively r = -0.27, 0.26, 0.24, p ≤ 0.05)
and most weakly with vigorous hours per day (r = 0.05).
IPAQ METs correlated most strongly with METs 3–6 and
METs 1–3 from ActiReg (r = 0.34 and -0.32, p ≤ 0.01).
Classification of PA in three levels correlated also most
strongly with VO2max (0.31 p ≤ 0.01) and METs 3–6 and
METs 1–3 from ActiReg (r = 0.32 and -0.31, p ≤ 0.01).
Classification of BMI in three levels correlated most
strongly negative with VO2max (-0.42 p ≤ 0.01) and MJ
from ActiReg (r = 0.31 p ≤ 0.01).
Discussion
In this study of young adult men, we found evidence for
good reliability with high correlations between the test –
retest for the IPAQ questionnaire for vigorous days, hours
and sitting hours per day and moderate for walking days
and hours. Reliability was further fair for moderate activ-
ity days and hours.
Concerning validity, our results suggest that total IPAQ
vigorous PA, was a moderately good measure of vigorous
activity, having moderately strong, significant correlations
Table 1: Physical characteristics, classification of BMI, VO2max (ml·kg-1·min-1) and normal values of maximal oxygen uptake at the age 
of 20–39 and in the validation study
Physical characteristics of subjects 20–39 year (N = 108)
Age (yr) Weight (kg) Height (cm) BMI
Mean SD Mean SD Mean SD Mean SD
Male 32.4 5.24 85.5 12.20 180.2 7.88 26.3 3.16
Classification of BMI among subjects
Age, yr < 18.50 18.50–24.99 25.00–29.99 30.00–34.9
20–29 1 10 16 4
30–39 23 45 9
Subjects characteristics of VO2max (ml·kg-1·min-1)
Age, yr (N) Low (N) Somewhat low (N) Average (N) High (N) Very high (N)
20–29 (31) 38 (3) 39–43 (10) 44–51 (13) 52–56 (4) 57 (1)
30–39 (77) 34 (2) 35–39 (8) 40–47 (40) 48–51 (12) 52 (15)
Normal values of maximal oxygen uptake, age of 20–39 and in the validation study
Normal values Validation study
Age, yr, men Mean SD Age, yr, men Mean SD
20–29 (ml·kg-1·min-1) 43 7.2 20–29 (ml·kg-1·min-1) 45.8 6.39
METs 12 METs 12.7
30–39 (ml·kg-1·min-1) 42 7.0 30–39 (ml·kg-1·min-1) 46.1 6.22
METs 12 METs 12.7
Values are expressed as mean and standard deviation (SD). MET indicate metabolic equivalent 3.5 ml·kg-1·min-1.Page 5 of 9
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or more measured with ActiReg. Only the IPAQ for walk-
ing had a fair correlation with METs 6+. The IPAQ sitting
hours per week was moderately correlated with METs val-
ues of 1–3 and negatively correlated with METs values of
3–6.
Reliability
Our study provides useful information about the repro-
ducibility of the IPAQ short version. The reliability ranged
from good for sitting and vigorous PA, and moderate for
walking, to fair for moderate activity. Brown et al. [21]
assessed test-retest reliability of four PA measures used in
population studies and one of them was the short IPAQ.
They pointed out that the ICC was lowest for the moder-
ate questions (0.16 to 0.44). In our study we also have the
lowest ICC for the moderate questions (0.16–0.51 and
0.09–0.49). Since the development of the IPAQ, the
EUPASS and the WHO have used it for monitoring and
Table 2: Means and standard deviations for responses to physical 
activity questionnaire (IPAQ short version, last 7 days) and 
criterion measures
Measures N Mean SD
Vigorous activity days/week 107 1.78 1.80
Vigorous activity hours/day 104 1.29 1.86
Moderate activity days/week 106 2.18 2.04
Moderate activity hours/day 93 1.27 1.67
Walking 10 min. days/week 105 3.55 2.71
Walking hours/day 95 1.11 2.22
Sitting hours/day 92 5.91 3.5
Total IPAQ METs min/week 84 4157.07 6095.86
3 PA categories 84 2.12 0.75
BMI 108 26.3 3.16
BMI 3 categories 108 1.81 0.63
VO2max (mL·kg-1·min-1) 108 45.99 6.24
ActiReg
EE (MJ1)) 93 12.71 1.82
PAL2) 93 1.68 0.2
METs1–33) 93 20.97 1.34
METs3–63) 93 2.69 1.26
METs 6+3) 93 0.27 0.26
1) average EE (MJ) per day
2) PAL = average physical activity level in 7 days
3) METs = average hours per day
3 PA categories = Classification of physical activity in three levels; 
"low", "moderate" and "high"
BMI (Body Mass Index) 3 categories = Classification of BMI in three 
levels ; "normal" (< 25 kg/m2), "overweight" (25–29.99) and "obese" 
(≥30 kg/m2)
Table 3: Test re-test reliability based on intraclass correlation 
coefficients (ICC) for the IPAQ (short version, last 7 days) 
questions (N = 108)
Questionnaire N = 108
ICC 95% CI
IPAQ
Vigorous activity (days per week) 0.61 0.48 – 0.72
Vigorous activity (hours per day) 0.62 0.47 – 0.73
Moderate activity (days per week) 0.34 0.16 – 0.51
Moderate activity (hours per day) 0.3 0.09 – 0.49
Walking (days per week) 0.56 0.41 – 0.68
Walking (hours per day) 0.42 0.23 – 0.59
Sitting (hours per day) 0.8 0.70 – 0.87
ICC = Single measure intraclass correlation coefficient
Table 4: Distribution of criterion measures based on VO2max and 
ActiReg by IPAQ (short version, last 7 days) questionnaire 
responses
Mean (SD) for Each Factor
Measures VO2max METs 1–32) METs 3–62) METs 6+2)
Vigorous activity hours/week1)
1 43.2 (4.5) 20.96 (1.50) 2.67 (1.41) 0.24 (0.28)
2-3 49.2 (6.1) 20.92 (1.23) 2.65 (1.09) 0.35 (0.27)
4-6 49.2 (5.5) 21.21 (1.00) 2.51 (1.05) 0.27 (0.19)
6+ 48.4 (6.9) 20.73 (1.33) 3.02 (1.27) 0.26 (0.29)
Moderate activity hours/week1)
1 44.7 (5.9) 21.08 (1.52) 2.57 (1.46) 0.26 (0.29)
2-3 48.3 (5.6) 21.25 (1.00) 2.40 (0.88) 0.27 (0.21)
4-6 47.7 (6.7) 21.09 (1.45) 2.69 (1.43) 0.21 (0.11)
6+ 45.5 (5.8) 20.28 (1.07) 3.43 (0.98) 0.29 (0.26)
Walking days least 10 min. hours/week1)
1 45.2 (6.4) 21.29 (1.32) 2.40 (1.22) 0.21 (0.18)
2-3 45.2 (7.0) 21.25 (1.23) 2.50 (1.20) 0.25 (0.19)
4-6 48.4 (6.9) 20.59 (1.31) 2.87 (1.14) 0.55 (0.38)
6+ 47.6 (5.4) 20.25 (1.31) 3.48 (1.39) 0.28 (0.17)
Sitting hours/week1)
3 45.7 (5.8) 20.38 (1.31) 3.22 (1.27) 0.23 (0.22)
4–6 46.1 (6.3) 20.80 (1.38) 2.88 (1.32) 0.27 (0.23)
7–12 47.2 (5.8) 21.59 (1.10) 2.07 (0.96) 0.27 (0.24)
13+ 43.6 (8.0) 22.44 (0.46) 1.36 (0.22) 0.20 (0.27)
1) see http://www.ipaq.ki.se for full text
2) METs = average hours per day.Page 6 of 9
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of the IPAQ may be associated with over-reporting of PA.
In one study, 75% of subjects reported less PA with the
modified procedure than with the short IPAQ telephone
survey [3]. Twenty three of the 50 individuals were found
to have reported some amounts of PA with IPAQ (either
walking, or vigorous or moderate PA) when they should
have reported none. The authors discuss how the IPAQ
protocol asks respondents to report average time per day
in each intensity category. In this way if PA is reported for
more than a day, the respondents may report an average
time per day and could over-report the mean time per day,
by reporting the day they were most active. Another study
gives some indirect support to overestimation of habitual
PA in obese [22]. In the EUPASS study [5] the test-retest
reliability scores of the IPAQ (short version, last 7 days tel-
ephone interview, S7T), were rather low. They concluded
that more research was needed to further investigate and
improve the quality of IPAQ.
Our results for re-test reliability of the IPAQ short version
were good for vigorous and fair for moderate activities.
The reliability of the IPAQ S7T from eight participating
EU countries in general ranged from 0.3 and 0.5, which
appears to be rather low for reliability. In the Chinese ver-
sion of IPAQ, the test-retest reliability was completed
twice with a three-day interval among college students
and validity by Caltrac accelerometer [6]. The short IPAQ
had ICC above 0.7 for PA. They concluded that both the
long and short version had acceptable reliability and
validity, compared to other PA instruments. However, the
short version, underestimated the EE of total and moder-
ate PA.
The IPAQ was developed to overcome differences in PA
measurement. However, the IPAQ is itself a new instru-
ment, making it difficult to compare it with other, older
questionnaires. Many other measurement studies focus
mainly on leisure time PA (LTPA). The study of Rütten et
al. [4] highlights some of the methodological innovations
of the IPAQ instrument. One is that many measurements
methods focus mainly on LTPA, while the IPAQ integrates
several domains and not only PA at work. This methodo-
logical shift may explain some of the differences i.e. in
overall scores for PA.
Table 5: Spearman correlation coefficients for IPAQ (short version, last 7 days) with the VO2max and ActiReg to assess criterion 
validity
Variables
Measures VO2max EE(MJ)1) PAL2) METs3)1–3 METs3) 3–6 METs3)6+
IPAQ short version (last 7 days)
Vigorous days/week 0.36** 0.07 0.08 0.01 0.03 0.09
Vigorous hours/day 0.40** 0.05 0.09 -0.04 0.09 0.05
Total IPAQ vigorous 0.41** 0.05 0.08 -0.02 0.08 0.07
Moderate days/week 0.15 0.21 0.17 -0.13 0.16 0.14
Moderate hours/day 0.18 0.17 0.11 -0.05 0.12 0.07
Total IPAQ moderate 0.19 0.16 0.14 -0.1 0.17 0.1
Walking days/week 0.18 0.05 0.08 -0.07 0.07 0.19
Walking hours/day 0.14 0.17 0.2 -0.17 0.17 0.23*
Total IPAQ walking 0.14 0.16 0.23* -0.27* 0.26* 0.24*
Total IPAQ sitting 0.07 -0.25* -0.35** 0.44** -0.42** 0.31
IPAQ Mets min/week 0.30** 0.26* 0.29* -0.32** 0.34** 0.15
3 PA categories 0.31** 0.19 0.24* -0.31** 0.32** 0.16
BMI 3 categories -0.42** 0.31** 0.45 -0.09 0.08 -0.08
* p < .05, ** p < .01.
1) average EE (MJ) per day
2) PAL = average physical activity level in 7 days
3) METs = average hours per day.
see http://www.ipaq.ki.se for full text
3 PA categories = classification of physical activity in three levels; "low" "moderate" and "high"
BMI 3 categories = Classification of BMI in three levels; "normal" (< 25 kg/m2), "overweight" (25–29.99) and "obese" (≥30 kg/m2)Page 7 of 9
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IPAQ and VO2max
Assessment of criterion validity depends on the validation
criteria. In our study VO2max was chosen as the primary cri-
terion. The results in this study are similar to those often
obtained in the general population with correlation coef-
ficients between PA and fitness typically 0.3–0.5 [23]. In a
study that evaluated 10 commonly used PA question-
naires [24], the correlation of VO2max was stronger with
reported heavy activity than for light activity. Fogelholm
et al. [9] validated IPAQ against fitness in men aged 21–
43 years. They found that a weekly frequency of vigorous
PA showed positive association with fitness. Fogelholm
found mostly similar characteristics of young men (aged
21–43) in their study as in ours (aged 20–39, Table 1). In
our study total vigorous PA, hours per week and days were
most strongly correlated (respectively 0.41, 0.40 and 0.36,
r= p ≤ 0.01) with VO2max.
IPAQ and ActiReg
To evaluate validity further we also used several directly
measured aspects of PA measures assessed with ActiReg,
including EE, PAL and METs 1–3. METs 3–6 and METs 6+.
METs values of 6 or more measured with ActiReg corre-
lated not, except for total IPAQ walking and walking
hours per week, which correlated fair with METs 6+. Sit-
ting hours per week correlated moderately with METs val-
ues of 1–3 (0.44) and negatively correlated with METs
values of 3–6 (-0.42). Ekelund et al. [10] indicated mod-
erate criterion validity of the IPAQ instrument and the
MTI Actigraph (Manufacturing Technology Inc., formerly
known as The Computer Science and Application, (CSA))
with correlation ranging from 0.16–0.35. Craig et al.
obtained the same correlation in their study [1]. In the
Chinese version of IPAQ [8] using an MTI accelerometer
there was weak agreement between IPAQ and the total
MTI – derived activity and sub-components. In our study
there is an average underestimation of IPAQ (total mod-
erate, vigorous and walking) with -433 min/week, limits
of agreement 1605 to – 2471 min/week compared to
ActiReg calculated in a Bland Altman plot (plot not
shown). We think that the main reason for the underesti-
mation by IPAQ is due to the fact that the questionnaire
only asks for time periods with duration of 10 min and
more, while ActiReg register each minute of the day with
sufficient PA. The Chinese short version of IPAQ [6] also
underestimated EE of total and moderate PA. Also Hallal
& Victora [7] reported possible underestimation of PA lev-
els.
IPAQ and total time of PA expenditure
The IPAQ especially focuses on investigation of total time
of PA energy expenditure (MET min -1) as these PA indica-
tors are associated with reduced cardiovascular diseases
and mortality and therefore have been applied in public
health recommendations [25]. Rütten et al. [4] compared
IPAQ results with other European studies and PA in the
IPAQ-S7T and Germany had the highest median of vigor-
ous PA, 26 min -1. In our study we had a mean of 16.11
average minutes per day or 0.27 hours per day assessed
with ActiReg and METs 6+. In the study of Ekelund et al.
[10] total self-reported PA (MET-min day -1) was signifi-
cantly correlated with average intensity of activity (counts
min -1) from accelerometry (r = 0.34, p < 0.001). Further
in our study IPAQ METs correlated most strongly with
METs 3–6 and METs 1–3 measured with ActiReg (r = 0.34
and -.032, p ≤ 0.01) and VO2max (r = 0.30, p ≤ 0.01) and
more weakly with total EE (MJ) and PAL (r = 0.26 and
0.29, p ≤ 0.05).
In our study the correlation between vigorous activity and
VO2max are quite good, but vigorous activity do not corre-
late wit ActiReg 6+. This stronger association with the
measures of vigorous activity is consistent with the pattern
found in comparisons using VO2max. The fair correlations
with weekly hours of time spent at > 6 METs measured
with ActiReg and the weaker association with other meas-
ures as with EE and PAL is not surprising. PAL is primarily
determined by time spent in activities with low and mod-
erate intensities, and that high intensity activity has little
impact on daily EE [26]. Probably this also is the answer
to why our result of walking correlates much better with
ActiReg than ActiReg and METs 6+. Our results suggest
that IPAQ S7S was a better measure of intense PA, rather
than EE. The study of criterion validity of IPAQ short ver-
sion in Swedish adults [10] showed that self-reported time
in PA was significantly different from time measured by
accelerometry.
Strengths of our study are use of two objective validation
measures, such as use of treadmill derived maximal oxy-
gen uptake values and ActiReg measuring PA and EE dur-
ing waking hours across a 7-day observation interval for
validation, and a one-week test-retest repeatability design.
Study strengths are also the random selection of study par-
ticipants from a larger existing study population. Previous
studies usually evaluating the validity of PA questionnaire
often include selected samples of volunteers, also IPAQ
itself [1]. The limitation is however, due to economic
resources at that time, a study of only men and the low
response-rate may affect the results because the likelihood
of bias. The age ranges is also narrow, which limits the
application of results to older men.
Conclusion
In conclusion, our results indicate that the IPAQ short ver-
sion for men has acceptable test-retest reliability and crite-
rion validity for vigorous activity and sitting. Walking has
moderate reliability. Only the IPAQ for walking had a fair
correlation with METs 6+. The IPAQ sitting hours perPage 8 of 9
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and negatively correlated with METs values of 3–6. The
questions about moderate activity had fair reproducibility
and correlated poorly with most comparison measures.
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